AKT1 and neoplasm: So, a treatment with blood-derived EVs with a coating of an inhibitor of miR-21 decreased tumor growth and induced sensitivity to doxorubicin in an in vivo glioblastoma model dependent on the inhibition of Akt phosphorylation [134].